Abiopharma

New Form 144 - Kiniksa Pharmaceuticals International, plc Filed: 2025-08-04 AccNo: 0001921094-25-000867 Size: 5 KB

Ardelyx Announces Changes to the Executive Leadership Team

New Form 8-K - GILEAD SCIENCES, INC. Filed: 2025-08-04 AccNo: 0000882095-25-000022 Size: 495 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073629 Size: 5 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004993 Size: 9 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004992 Size: 9 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004991 Size: 11 KB

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Best Bathroom Dehumidifier Options for Humidity Control in 2025

New Form 144 - TransMedics Group, Inc. Filed: 2025-08-04 AccNo: 0001950047-25-005380 Size: 6 KB

New Form 8-K - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-08-04 AccNo: 0000875320-25-000213 Size: 422 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Inovio - INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

New Form 4 - Altimmune, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073627 Size: 6 KB

New Form 4 - Tilray Brands, Inc. Filed: 2025-08-04 AccNo: 0001171843-25-004990 Size: 9 KB